John Tedesco, DO
Plastic and Reconstructive Surgery · Tulsa, OKNPI 1790951747
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by AbbVie at 33.7% of the total. 2025 is the largest year on record at $558, 4.2 times the $133 reported in 2019. That places this record below the midpoint for plastic and reconstructive surgery clinicians in OK, where the typical reported total is $3,788.
Across 29 payments — averaging $59.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$587
- BD$350
- Organogenesis Inc.$293
- Medtronic$195
- Pacira Pharmaceuticals Incorporated$140
- Kowa Pharmaceuticals America, Inc.$70
- plus $105 from 4 others
Across 4 payments — averaging $11,164 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mentor Worldwide LLC$35K
- Davol Inc.$9K
What the payments were for
- Consulting fees$58534%
- Speaking & faculty fees$35020%
- Food & beverage$80446%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 4 | $587 |
| BD | 1 | $350 |
| Organogenesis Inc. | 7 | $293 |
| Medtronic | 6 | $195 |
| Pacira Pharmaceuticals Incorporated | 2 | $140 |
| Kowa Pharmaceuticals America, Inc. | 4 | $70 |
| Smith+Nephew | 2 | $38 |
| Vertex | 1 | $32 |
| Davol Inc. | 1 | $18 |
| TELA Bio, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,739 in reported general payments places this provider in the 20th percentile of 22 plastic and reconstructive surgery providers in Oklahoma.
See all plastic and reconstructive surgery providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 67 | $475 |
| Cephalexin | 17 | $145 |
| Ondansetron OdtOndansetron | 14 | $92 |
| Diazepam | 20 | $21 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Tulsa
- Archibald MillerTulsa$415K
- Stephen PaulsenTulsa$27K
- Greg RatliffTulsa$13K
- Scott NewbroughTulsa$4K
- Angie HigniteTulsa$4K
- Shaw TangTulsa$3K
- Laurie DuckettTulsa$3K
- Scott KreitzbergTulsa$3K
- Brent RubisTulsa$2K
- Brenda SchieselTulsa$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.